Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Renal Cell 5Neoplasms 4Carcinoma, Hepatocellular 4Lung Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Ovarian Neoplasms 2Neoplasm, Residual 2NSCLC 2Kidney Neoplasms 2Colorectal Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Recurrence 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Philadelphia Chromosome 1Neoplasms, Second Primary 1Neoplasms by Site 1Lung Diseases 1Liver Neoplasms 1Leukemia, Biphenotypic, Acute 1Leukemia 1

Interventions

Cyclophosphamide 56Cytarabine 43fludarabine phosphate 37Methotrexate 35Whole-Body Irradiation 32Mycophenolic Acid 29Filgrastim 27fludarabine 25Peripheral Blood Stem Cell Transplantation 22Vincristine 21Cyclosporine 20Busulfan 19Dexamethasone 18Specimen Handling 17Methylprednisolone 17venetoclax 16Granulocyte Colony-Stimulating Factor 16Tacrolimus 15Hydrocortisone 15Melphalan 14Daunorubicin 14Asparaginase 14merphos 13Thiotepa 13Mercaptopurine 13Leucovorin 13Cord Blood Stem Cell Transplantation 13Antilymphocyte Serum 13Calcium Dobesilate 11Biopsy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Tyrosine Kinase Inhibitors × Clear all
NCT04440267 2025-08-06

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
50 enrolled
Other hematologic neoplasm

Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡